SENSEX 75,200.85
NIFTY 23,618.00
CRUDEOIL 10,035.00
+ 111.00
GOLD 159,100.00
The merger expands the combined entity’s manufacturing, research, and development capabilities, with a focus on specialty drugs for oncology, autoimmune disorders, chronic
SENSEX 75,200.85
NIFTY 23,618.00
CRUDEOIL 10,035.00
+ 111.00
GOLD 159,100.00

They will focus on developing scientifically validated biochar-integrated fertilizer formulations that enhance soil fertility,…

Consolidated net profit in Q1 rises to ₹2,895 crore ($303.54 million) from ₹2,279 crore a year earlier

Of the proceeds from fresh share issuance, the company will use ₹208 crore for debt repayment, ₹167 crore for purchase of…

Q4 Results Today, 18th May 2026: Find all the latest Q4 results 2026 updates of 63 Moons Technologies, Afcons Infrastructure,…

The platform will target energy-intensive sectors including pharmaceuticals, automotive, food and beverage, chemicals, cement,…

Partnership to ensure a reliable supply of a key industrial input while promoting greater resource optimisation, operational…